descriptive
Analysis v1
Strong Support
The drug lowered the genetic instructions in the liver for making the bad cholesterol protein, but didn’t change the instructions for clearing it from the blood.
11
0
Evidence from Studies
Supporting (1)
11
Community contributions welcome
11
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Randomized Controlled Trial
Animal
1997 NovThe study gave pigs a cholesterol-lowering drug called atorvastatin for 21 days and found it lowered a specific liver protein message (apoB mRNA) by 13%, just like the claim said — and it didn’t change other related messages in the liver or intestine.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.